Find Propofol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

16RELATED EXCIPIENT COMPANIES

26EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 2,6-diisopropylphenol, 2078-54-8, Diprivan, Disoprofol, Disoprivan, Fresofol
Molecular Formula
C12H18O
Molecular Weight
178.27  g/mol
InChI Key
OLBCVFGFOZPWHH-UHFFFAOYSA-N
FDA UNII
YI7VU623SF

Propofol
An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
Propofol is a General Anesthetic. The physiologic effect of propofol is by means of General Anesthesia.
1 2D Structure

Propofol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,6-di(propan-2-yl)phenol
2.1.2 InChI
InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3
2.1.3 InChI Key
OLBCVFGFOZPWHH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)C1=C(C(=CC=C1)C(C)C)O
2.2 Other Identifiers
2.2.1 UNII
YI7VU623SF
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2,6 Diisopropylphenol

2. 2,6-bis(1-methylethyl)phenol

3. 2,6-diisopropylphenol

4. Aquafol

5. Diprivan

6. Disoprivan

7. Disoprofol

8. Fresofol

9. Ici 35,868

10. Ici 35868

11. Ici-35,868

12. Ici-35868

13. Ici35,868

14. Ici35868

15. Ivofol

16. Propofol Abbott

17. Propofol Fresenius

18. Propofol Mct

19. Propofol Rovi

20. Propofol-lipuro

21. Recofol

2.3.2 Depositor-Supplied Synonyms

1. 2,6-diisopropylphenol

2. 2078-54-8

3. Diprivan

4. Disoprofol

5. Disoprivan

6. Fresofol

7. Diisopropylphenol

8. 2,6-bis(1-methylethyl)phenol

9. Ampofol

10. Rapinovet

11. Phenol, 2,6-bis(1-methylethyl)-

12. 2,6-di(propan-2-yl)phenol

13. Propofolum

14. Recofol

15. Ivofol

16. Propofol-lipuro

17. Pofol

18. Ici 35868

19. 2,6-diisopropyl Phenol

20. Diprifusor

21. Diprofol

22. Propovan

23. Phenol, 2,6-diisopropyl-

24. Diprivan 10

25. Ici-35868

26. Lipuro

27. Nsc 5105

28. Ici 35,868

29. 2,6-bis(propan-2-yl)phenol

30. 2,6-diisopropyl-phenol

31. Ici35,868

32. Mfcd00008885

33. Chembl526

34. Yi7vu623sf

35. Chebi:44915

36. Nsc5105

37. 2,6-di-iso-propylphenol-d18

38. Phenol, 2,6-bis(1-methylethyl)

39. Nsc-5105

40. Ici 35-868

41. Propofolum [latin]

42. Ncgc00015389-08

43. Aquafol

44. Cas-2078-54-8

45. Dsstox_cid_3523

46. Dsstox_rid_77063

47. Dsstox_gsid_23523

48. Diprivan Injectable Emulsion

49. 2,6 Diisopropylphenol

50. Dipravan

51. Propoven

52. Aquafo

53. Propofol Idd-d

54. Diprivan (tn)

55. Smr000059151

56. Ccris 9000

57. Propofol(2,6-diisopropylphenol)

58. Hsdb 7123

59. 2, 6-diisopropylphenol

60. Sr-01000075468

61. Einecs 218-206-6

62. 2,6-bis(isopropyl)phenol

63. Unii-yi7vu623sf

64. Brn 1866484

65. Dds-04f

66. Ghl.pd_mitscher_leg0.558

67. Ai3-26295

68. Propofol Solution

69. Propofol [usan:usp:inn:ban]

70. Propofol (diprivan)

71. Zd-0859

72. Phenol,6-diisopropyl-

73. Propofol [hsdb]

74. Propofol [usan]

75. Propofol [inn]

76. Propofol [jan]

77. Propofol [mi]

78. Propofol [vandf]

79. Prestwick0_000931

80. Prestwick1_000931

81. Prestwick2_000931

82. Prestwick3_000931

83. 2,6-di Isopropyl Phenol

84. Propofol [mart.]

85. 2,6-dipropan-2-ylphenol

86. Biomol-nt_000248

87. Lopac-d126608

88. Propofol [usp-rs]

89. Propofol [who-dd]

90. Diisopropylphenol (related)

91. Propofol (jan/usp/inn)

92. Lopac0_000437

93. Schembl36245

94. Bspbio_000862

95. 4-06-00-03435 (beilstein Handbook Reference)

96. Mls001066348

97. Mls001335999

98. Mls002454360

99. Bidd:gt0436

100. Propofol [green Book]

101. Spectrum1505022

102. Spbio_003031

103. 2,6-diisopropylphenol, 97%

104. Propofol [ep Impurity]

105. Propofol [orange Book]

106. Bpbio1_000950

107. Bpbio1_000969

108. Gtpl5464

109. Phenol,6-bis(1-methylethyl)-

110. Propofol [ep Monograph]

111. Propofol [usp Impurity]

112. Dtxsid6023523

113. Propofol [usp Monograph]

114. Ketafol Component Propofol

115. Propofol 1.0 Mg/ml In Methanol

116. 2,6-diisopropylphenol, >=97%

117. 3f33

118. 3p50

119. Hms1570l04

120. Hms2089o21

121. Hms2094e17

122. Hms2097l04

123. Hms2231e16

124. Hms3259e03

125. Hms3261g16

126. Hms3369i16

127. Hms3714l04

128. Pharmakon1600-01505022

129. Zinc968303

130. Albb-036351

131. Bcp02920

132. Hy-b0649

133. Tox21_110134

134. Tox21_201371

135. Tox21_303225

136. Tox21_500437

137. Ac8633

138. Bdbm50058046

139. Nsc758909

140. Phenol, 2, 6-bis(1-methylethyl)-

141. Akos009159417

142. Tox21_110134_1

143. Ac-2038

144. Am90311

145. Ccg-204529

146. Cs-w020057

147. Db00818

148. Lp00437

149. Nc00449

150. Nsc-758909

151. Sdccgmls-0318084.p029

152. Sdccgsbi-0050422.p002

153. 2,6-diisopropylphenol; Propofol

154. Mls-0318084

155. Ncgc00015389-01

156. Ncgc00015389-02

157. Ncgc00015389-03

158. Ncgc00015389-04

159. Ncgc00015389-05

160. Ncgc00015389-06

161. Ncgc00015389-07

162. Ncgc00015389-09

163. Ncgc00015389-10

164. Ncgc00015389-11

165. Ncgc00015389-14

166. Ncgc00015389-17

167. Ncgc00091538-01

168. Ncgc00091538-02

169. Ncgc00091538-03

170. Ncgc00091538-04

171. Ncgc00091538-05

172. Ncgc00091538-06

173. Ncgc00257228-01

174. Ncgc00260670-01

175. Ncgc00261122-01

176. As-13299

177. Sy013479

178. 2,6-diisopropylphenol, Analytical Standard

179. Bcp0726000298

180. Mls-0318084.p017

181. Ab00513968

182. D0617

183. Eu-0100437

184. C07523

185. D00549

186. Ab00513968-07

187. Ab00513968_08

188. A814898

189. D126608

190. Q422740

191. Q-201631

192. Sr-01000075468-1

193. Sr-01000075468-4

194. Sr-01000075468-6

195. Brd-k82255054-001-03-5

196. Brd-k82255054-001-08-4

197. Propofol, British Pharmacopoeia (bp) Reference Standard

198. Propofol, European Pharmacopoeia (ep) Reference Standard

199. Z1245735300

200. Propofol, United States Pharmacopeia (usp) Reference Standard

201. Propofol, Pharmaceutical Secondary Standard; Certified Reference Material

202. Propofol For Peak Identification, European Pharmacopoeia (ep) Reference Standard

203. Propofol Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material

204. 113981-41-2

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 178.27 g/mol
Molecular Formula C12H18O
XLogP33.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count2
Exact Mass178.135765193 g/mol
Monoisotopic Mass178.135765193 g/mol
Topological Polar Surface Area20.2 Ų
Heavy Atom Count13
Formal Charge0
Complexity135
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameDiprivan
PubMed HealthPropofol (Injection)
Drug ClassesSedative-Hypnotic
Drug LabelFor IV Administration OnlyRx OnlyStrict aseptic technique must always be maintained during handling. Diprivan Injectable Emulsion is a single-use parenteral product which contains 0.005% disodium edetate to inhibit the rate of growth of microorgani...
Active IngredientPropofol
Dosage FormInjectable
RouteInjection
Strength10mg/ml
Market StatusPrescription
CompanyFresenius Kabi Usa

2 of 4  
Drug NamePropofol
PubMed HealthPropofol (Injection)
Drug ClassesSedative-Hypnotic
Drug LabelPropofol injectable emulsion is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration. Propofol is chemically described as 2,6-diisopropylphenol and has a molecular weight of 178.27. The structural a...
Active IngredientPropofol
Dosage FormInjectable
Routeinjection; Injection
Strength10mg/ml
Market StatusTentative Approval; Prescription
CompanyHospira; Teva Pharms Usa; Gensia Sicor Pharms; Baxter Hlthcare; Esi Lederle

3 of 4  
Drug NameDiprivan
PubMed HealthPropofol (Injection)
Drug ClassesSedative-Hypnotic
Drug LabelFor IV Administration OnlyRx OnlyStrict aseptic technique must always be maintained during handling. Diprivan Injectable Emulsion is a single-use parenteral product which contains 0.005% disodium edetate to inhibit the rate of growth of microorgani...
Active IngredientPropofol
Dosage FormInjectable
RouteInjection
Strength10mg/ml
Market StatusPrescription
CompanyFresenius Kabi Usa

4 of 4  
Drug NamePropofol
PubMed HealthPropofol (Injection)
Drug ClassesSedative-Hypnotic
Drug LabelPropofol injectable emulsion is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration. Propofol is chemically described as 2,6-diisopropylphenol and has a molecular weight of 178.27. The structural a...
Active IngredientPropofol
Dosage FormInjectable
Routeinjection; Injection
Strength10mg/ml
Market StatusTentative Approval; Prescription
CompanyHospira; Teva Pharms Usa; Gensia Sicor Pharms; Baxter Hlthcare; Esi Lederle

4.2 Therapeutic Uses

Propofol is indicated for the induction of general anesthesia. It is also indicated for the maintenance of anesthesia utilizing balanced techniques with other appropriate agents such as opioids and inhalation anesthetics.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2466


Propofol is indicated for the sedation in critically ill patients confined to intensive care units.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2466


Propofol has successfully controlled seizures in status epilepticus.

Ellenhorn, M.J., S. Schonwald, G. Ordog, J. Wasserberger. Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams and Wilkins, 1997., p. 1181


Propofol appears to have significant antiemetic action and is a good choice for sedation or anesthesia in patients at high risk for nausea and vomiting.

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 345


4.3 Drug Warning

Compromised cardiovascular function may be aggravated by cardiovascular-depressant and hypotensive effects.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2467


Caution is also recommended in geriatric, debilitated, and/or hypovolemic patients, because they may require lower induction and maintenance doses.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2468


Substantial decreases in mean arterial pressure and cerebral perfusion may occur in patients with existing impaired cerebral circulation or increased intracranial pressure.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2468


Rarely, a clinical syndrome including bronchospasm, erythema, and hypotension has occured shortly after administration of propofol, and sequelae including anoxic brain damage and death have been reported. /SRP: May be from metabisulfite./

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2468


For more Drug Warnings (Complete) data for PROPOFOL (17 total), please visit the HSDB record page.


4.4 Drug Indication

Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Propofol is a sedative-hypnotic agent for use in the induction and maintenance of anesthesia or sedation. Intravenous injection of a therapeutic dose of propofol produces hypnosis rapidly with minimal excitation, usually within 40 seconds from the start of an injection (the time for one arm-brain circulation).


5.2 MeSH Pharmacological Classification

Anesthetics, Intravenous

Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)


Hypnotics and Sedatives

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
PROPOFOL
5.3.2 FDA UNII
YI7VU623SF
5.3.3 Pharmacological Classes
General Anesthetic [EPC]; General Anesthesia [PE]
5.4 ATC Code

N01AX10

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


N - Nervous system

N01 - Anesthetics

N01A - Anesthetics, general

N01AX - Other general anesthetics

N01AX10 - Propofol


5.5 Absorption, Distribution and Excretion

Absorption

Rapid - time to onset of unconsciousness is 15-30 seconds, due to rapid distribution from plasma to the CNS. Distribution is so rapid that peak plasma concentrations cannot be readily measured. Duration of action is 5-10 minutes.


Route of Elimination

It is chiefly eliminated by hepatic conjugation to inactive metabolites which are excreted by the kidney.


Volume of Distribution

60 L/kg [healthy adults]


Clearance

23 - 50 mL/kg/min

1.6 - 3.4 L/min [70 Kg adults]


The initial apparent volume of distribution is 13 to 76 L/kg.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2467


Propofol is rapidly and extensively distributed in the body. It crosses the blood-brain barrier quickly, and its short duration of action is due to rapid redistribution from the CNS to other tissues, high metabolic clearance and high lipophilicity.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2467


Approximately 70% of a dose is excreted in the urine within 24 hours after administration, and 90% is excreted within 5 days. Clearance of propofol ranges from 1.6 to 3.4 liters per minute in healthy 70 kg patients. As the age of the patient increases, total clearance of propofol may decrease. Clearance rates of 1.4 to 2.2 liters per minute in patients 18 to 35 years of age have been reported, in contrast to clearance rates of 1.0 to 1.8 liters per minute in patients 65 to 80 years of age.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2467


The pharmacokinetics of propofol were best described by a three-compartment model. Weight was found to be a significant covariate for elimination clearance, the two intercompartmental clearances, and the volumes of the central compartment, the shallow peripheral compartment, and the deep peripheral compartment; power functions with exponents smaller than 1 yielded the best results. The estimates of these parameters for a 70-kg adult were 1.44 l/min, 2.25 l/min, 0.92 l/min, 9.3 l, 44.2 l, and 266 l, respectively. For patients older than 60 yr the elimination clearance decreased linearly. The volume of the central compartment decreased with age. For children, all parameters were increased when normalized to body weight. Venous data showed a decreased elimination clearance; bolus data were characterized by increases in the volumes of the central and shallow peripheral compartments and in the rapid distribution clearance (Cl2) and a decrease in the slow distribution clearance (Cl3). Pharmacokinetics of propofol can be well described by a three-compartment model. Inclusion of age and weight as covariates significantly improved the model. Adjusting pharmacokinetics to the individual patient should improve the precision of target-controlled infusion and may help to broaden the field of application for target-controlled infusion systems.

PMID:10719952 Schuttler J, Ihmsen H; Anesthesiology 92 (3): 727-38 (2000)


An iv dose of 14C-propofol (0.47 mg/kg) administered to 6 male volunteers was rapidly eliminated with 88% recovered in the urine in 5 days and <2% in feces. The dose was cleared by metabolism with <0.3% excreted unchanged. The major metabolites were the glucuronic acid conjugate of propofol and the glucuronic acid and sulfate conjugates of its hydroxylated derivative, 2,6-diisopropyl-1,4-quinol. Propofol glucuronide accounted for about 53% of the urinary radioactivity and was the major metabolite in plasma from 30 min post dose. The blood concentration of propofol declined in a biphasic manner from a maximum mean value of 0.44 ug/ml, 2 min after injection. The half-lives of the first and second exponential phases, mean values 5 min and 97 min respectively, varied widely among subjects. A proportion of the dose was cleared slowly, probably due to slow release from less well perfused tissues. Propofol accounted for 94% of the total blood radioactivity at 2 min but only about 6% from 3 to 8 hr post dose. Propofol has a volume of distribution equivalent to about 3 to 4 times body weight, and a mean total body clearance of 2.2 l/min.

PMID:3261062 Simons P, Cockshott I; Xenobiotica 18 (4): 429-40 (1988)


5.6 Metabolism/Metabolites

Hepatically metabolized mainly by glucuronidation at the C1-hydroxyl. Hydroxylation of the benzene ring to 4-hydroxypropofol may also occur via CYP2B6 and 2C9 with subsequent conjugation to sulfuric and/or glucuronic acid. Hydroxypropofol has approximately 1/3 of hypnotic activity of propofol.


Hepatic; rapidly undergoes glucuronide conjugation to inactive metabolites. An unidentified route of extrahepatic metabolism may also exist, suggested by the fact that propofol clearance exceeds estimated hepatic blood flow.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2467


To determine the cytochrome P450 (CYP) isoforms involved in the oxidation of propofol by human liver microsomes. The rate constant calculated from the disappearance of propofol in an incubation mixture with human liver microsomes and recombinant human CYP isoforms was used as a measure of the rate of metabolism of propofol. The correlation of these rate constants with rates of metabolism of CYP isoform-selective substrates by liver microsomes, the effect of CYP isoform-selective chemical inhibitors and monoclonal antibodies on propofol metabolism by liver microsomes, and its metabolism by recombinant human CYP isoforms were examined. The mean rate constant of propofol metabolism by liver microsomes obtained from 6 individuals was 4.2 (95% confidence intervals 2.7, 5.7) nmol/min/mg protein. The rate constants of propofol by microsomes were significantly correlated with S-mephenytoin N-demethylation, a marker of CYP2B6 (r=0.93, P<0.0001), but not with the metabolic activities of other CYP isoform-selective substrates. Of the chemical inhibitors of CYP isoforms tested, orphenadrine, a CYP2B6 inhibitor, reduced the rate constant of propofol by liver microsomes by 38% (P<0.05), while other CYP isoform-selective inhibitors had no effects. Of the recombinant CYP isoforms screened, CYP2B6 produced the highest rate constant for propofol metabolism (197 nmol/min/nmol P450). An antibody against CYP2B6 inhibited the disappearance of propofol in liver microsomes by 74% /and SRP: reduced in vitro metabolism by blocking CYP 2B6/. Antibodies raised against other CYP isoforms had no effect on the metabolism of propofol. CYP2B6 is predominantly involved in the oxidation of propofol by human liver microsomes.

Oda Y, Hamaoka N; Br J Clin Pharmacol 51 (3): 281-5 (2001


Propofol has known human metabolites that include (2S,3S,4S,5R)-6-[2,6-Di(propan-2-yl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid and 4-hydroxy-propofol.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


5.7 Biological Half-Life

Initial distribution phase t1/2α=1.8-9.5 minutes. Second redistirubtion phase t1/2β=21-70 minutes. Terminal elimination phase t1/2γ=1.5-31 hours.


Terminal elimination half-life is 3 to 12 hours; prolonged administration may result in longer duration.

MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2467


...The first-stage elimination half-life (t1/2 beta) of propofol /SRP: administered mixed with lidocaine/ in children was shorter (mean 9.3 +/- 3.8 (s.d.) min) than the values found in adults. This pharmacokinetic alteration may have clinical significance following repeated administration or continuous infusion of propofol.

PMID:2646847 Valtonen M, et al; Acta Anaesthesiol Scand 33 (2): 152-5 (1989)


An intravenous dose of 14C-propofol (0.47 mg/kg) /was/ administered to six male volunteers... . ...The half-lives of the first and second exponential phases, mean values 5 min and 97 min respectively, varied widely among subjects.

PMID:3261062 Simons P, Cockshott I; Xenobiotica 18 (4): 429-40 (1988)


5.8 Mechanism of Action

The action of propofol involves a positive modulation of the inhibitory function of the neurotransmitter gama-aminobutyric acid (GABA) through GABA-A receptors.


API SUPPLIERS

read-more
read-more

01

Bachem AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF arrow-down VMF Others AUDIT
Bachem company banner

02

ASolution Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothASolution Pharmaceuticals: Your CDMO Partner for APIs and Specialty Molecules.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
ASolution Pharmaceuticals

03

Transo-Pharm USA LLC

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF US arrow-down AUDIT
Transo Pharm USA Company Banner

04

Seqens

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Seqens Company Banner

05

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
HRV Global Life Sciences

06

Neuland Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF arrow-down VMF Others AUDIT arrow-down
Neuland

07

Supriya Lifescience

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Supriya

08

Zeon Pharma Industries India Pvt L...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Zeon Pharma Industries India Pvt Ltd

09

SNJ Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSNJ Labs: WHO-GMP certified API leader in India, specializing in bulk drugs & intermediates with unmatched expertise.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

10

Shamrock Pharmachemi

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTogether we can improve the quality of life

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Bachem Sa

Switzerland
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-03-14

Pay. Date : 2012-12-18

DMF Number : 11204

Submission : 1994-11-22

Status : Active

Type : II

Bachem company banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 27418

Submission : 2013-08-13

Status : Active

Type : II

Neuland

03

AACR Annual meeting
Not Confirmed

03

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 11474

Submission : 1995-04-26

Status : Inactive

Type : II

blank

04

Zeneca Pharmaceuticals

United Kingdom

USDMF

arrow
AACR Annual meeting
Not Confirmed

04

Zeneca Pharmaceuticals

United Kingdom
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 8915

Submission : 1991-01-04

Status : Inactive

Type : II

blank

05

AACR Annual meeting
Not Confirmed

05

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 15793

Submission : 2002-01-09

Status : Inactive

Type : II

blank

06

Novadel Pharma Inc

U.S.A

USDMF

arrow
AACR Annual meeting
Not Confirmed

06

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17850

Submission : 2004-11-22

Status : Inactive

Type : II

blank

07

Si Group

U.S.A

USDMF

arrow
AACR Annual meeting
Not Confirmed

07

Si Group

U.S.A
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-08-20

Pay. Date : 2013-01-09

DMF Number : 11777

Submission : 1995-12-08

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content
CEP 2005-003 - Rev 05
Valid
Chemical
2024-09-04
1558
Bachem company banner

01

BACHEM SA Vionnaz CH

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

Certificate Number : CEP 2005-003 - Rev 05

Status : Valid

Issue Date : 2024-09-04

Type : Chemical

Substance Number : 1558

Bachem company banner

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : CEP 2024-066 - Rev 00

Status : Valid

Issue Date : 2024-07-12

Type : Chemical

Substance Number : 1558

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : R1-CEP 2004-313 - Rev 01

Status : Withdrawn by Holder

Issue Date : 2017-03-01

Type : Chemical

Substance Number : 1558

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : R0-CEP 2022-494 - Rev 00

Status : Valid

Issue Date : 2023-08-07

Type : Chemical

Substance Number : 1558

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : CEP 2015-347 - Rev 02

Status : Valid

Issue Date : 2025-04-02

Type : Chemical

Substance Number : 1558

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : R0-CEP 2021-363 - Rev 00

Status : Valid

Issue Date : 2022-02-08

Type : Chemical

Substance Number : 1558

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : CEP 2002-229 - Rev 05

Status : Valid

Issue Date : 2025-05-30

Type : Chemical

Substance Number : 1558

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : R0-CEP 2004-218 - Rev 00

Status : Withdrawn by Holder

Issue Date : 2005-10-13

Type : Chemical

Substance Number : 1558

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

Propofol

Registration Number : 221MF10007

Registrant's Address : Route du simplon 22, CH-1895 Vionnaz-Switzerland

Initial Date of Registration : 2009-01-13

Latest Date of Registration : 2013-03-14

Bachem company banner

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Propofol

Registration Number : 219MF10087

Registrant's Address : #997-8, Daechi-3 Dong, Gennam Gu, Seoul, Korea

Initial Date of Registration : 2007-03-14

Latest Date of Registration : 2007-03-14

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Propofol

Registration Number : 223MF10043

Registrant's Address : 715, Yeongdong-daero, Gangnam-gu, Seoul, Korea

Initial Date of Registration : 2011-03-11

Latest Date of Registration : 2011-03-11

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Propofol

Registration Number : 218MF10683

Registrant's Address : 1790 Hughes Landing Blvd Suite 600, The Woodlands, TX 77380 US

Initial Date of Registration : 2006-08-11

Latest Date of Registration : 2017-09-08

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothASolution Pharmaceuticals: Your CDMO Partner for APIs and Specialty Molecules.

Flag India
Digital Content Digital Content

Propofol IP/BP/EP/USP

Date of Issue : 2024-01-23

Valid Till : 2026-06-17

Written Confirmation Number : WC-0476

Address of the Firm : K3/8, Anand Nagar, MIDC., Ambernath (East), Ambernath-421506, District: Thane, M...

ASolution Pharmaceuticals

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content

Propofol USP/Ph. Eur

Date of Issue : 2025-06-27

Valid Till : 2028-06-16

Written Confirmation Number : WC-0037

Address of the Firm : Unit-ll, Plot No. 92-94, 257-259, IDA Pashamylaram, Pashamylaram Village, Patanc...

Neuland

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Propofol EP

Date of Issue : 2025-09-26

Valid Till : 2028-07-02

Written Confirmation Number : WC-0226

Address of the Firm : D-24 & D-24/1, M.I.D.C., Kurkumbh, Taluka: Daund, District. Pune -413802, Mahara...

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Propofol EP/USP

Date of Issue : 2025-11-12

Valid Till : 2028-11-11

Written Confirmation Number : WC-0045

Address of the Firm : Plot No. E-7, E-8, E-9, MIDC Industrial Area, Chikalthana, Aurangabad-431006 Mah...

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Propofol EP/USP

Date of Issue : 2019-07-22

Valid Till : 2022-07-21

Written Confirmation Number : WC-0045A3

Address of the Firm : Plot No. E-7, E-8, E-9, MIDC Industrial Area, Chikalthana, Aurangabad -431 006, ...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

propofol

Registrant Name : Daewon Pharmaceutical Co., Ltd.

Registration Date : 2023-02-15

Registration Number : 20200806-210-J-463(4)

Manufacturer Name : Bachem SA

Manufacturer Address : Succursale of Vionnaz, Route du Simplon 22, 1895 Vionnaz, Switzerland

Bachem company banner

02

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

propofol

Registrant Name : Dongkook Pharmaceutical Co., Ltd.

Registration Date : 2021-12-02

Registration Number : 20200806-210-J-463(3)

Manufacturer Name : Bachem SA

Manufacturer Address : Succursale of Vionnaz, Route du Simplon 22, 1895 Vionnaz, Switzerland

Bachem company banner

03

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

propofol

Registrant Name : B. Braun Korea Co., Ltd.

Registration Date : 2025-11-12

Registration Number : 20200806-210-J-463(5)

Manufacturer Name : Bachem SA

Manufacturer Address : Succursale of Vionnaz, Route du Simplon 22, 1895 Vionnaz, Switzerland

Bachem company banner

04

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

propofol

Registrant Name : Myeongmun Pharmaceutical Co., Ltd.

Registration Date : 2021-03-02

Registration Number : 20200806-210-J-463(2)

Manufacturer Name : Bachem SA

Manufacturer Address : Succursale of Vionnaz, Route du Simplon 22, 1895 Vionnaz, Switzerland

Bachem company banner

05

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

propofol

Registrant Name : Fresenius Kabi Korea Co., Ltd.

Registration Date : 2020-08-06

Registration Number : 20200806-210-J-463

Manufacturer Name : Bachem SA

Manufacturer Address : Succursale of Vionnaz, Route du Simplon 22, 1895 Vionnaz, Switzerland

Bachem company banner

06

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

propofol

Registrant Name : Hana Pharmaceutical Co., Ltd.

Registration Date : 2021-01-18

Registration Number : 20200806-210-J-463(1)

Manufacturer Name : Bachem SA

Manufacturer Address : Succursale of Vionnaz, Route du Simplon 22, 1895 Vionnaz, Switzerland

Bachem company banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content

propofol

Registrant Name : Myeongmun Pharmaceutical Co., Ltd.

Registration Date : 2021-03-25

Registration Number : 20210325-210-J-630

Manufacturer Name : Neuland Laboratories Limited

Manufacturer Address : Plot Nos 92, 93, 94, 257, 258, 259, IDA, Pashamylaram, Isnapur (V), Patancheru (M), S...

Neuland

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

propofol

Registrant Name : Fresenius Kabi Korea Co., Ltd.

Registration Date : 2020-10-06

Registration Number : 20201006-210-J-526

Manufacturer Name : SI Group, Inc

Manufacturer Address : 725 Cannon Bridge Road, Orangeburg, SC 29115 United States of America

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Bachem AG

Switzerland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Flag Switzerland
Digital Content Digital Content

Propofol

About the Company : Bachem, with over 50 years of experience, supplies products for research, clinical development, and commercial use to pharmaceutical and biotechnology companies worldwide. It has e...

Bachem, with over 50 years of experience, supplies products for research, clinical development, and commercial use to pharmaceutical and biotechnology companies worldwide. It has established itself as a leading, innovation-driven specialist in developing and manufacturing peptides and oligonucleotides. Headquartered in Switzerland with offices in Europe, the US, and Asia, Bachem is publicly listed on the SIX Swiss Exchange. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Bachem company banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothASolution Pharmaceuticals: Your CDMO Partner for APIs and Specialty Molecules.

Flag India
Digital Content Digital Content

Propofol

About the Company : Established in 2010, ASolution is an India-based custom developer and manufacturer serving pharmaceutical needs across multiple scales. The company provides process development, op...

Established in 2010, ASolution is an India-based custom developer and manufacturer serving pharmaceutical needs across multiple scales. The company provides process development, optimization, and manufacturing services for APIs and specialty molecules. With a quality-driven team and regulatory-focused approach, ASolution supports long-term partnerships and sustainable growth. Operations are approved by US FDA, MFDS, and WHO-GMP, reflecting a strong commitment to compliance, integrity, and timely delivery. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
ASolution Pharmaceuticals

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Flag U.S.A
Digital Content Digital Content

Propofol

About the Company : Transo-Pharm is a licensed distributor of pharmaceutical components for human and veterinary markets. The company supports the full API life cycle, from development to sales, and a...

Transo-Pharm is a licensed distributor of pharmaceutical components for human and veterinary markets. The company supports the full API life cycle, from development to sales, and acts as a sourcing and regulatory marketing agent for API manufacturers. Transo-Pharm assists with DMF setup, GMP consulting, and regulatory activities, supported by a regulatory team, warehouse facilities, proprietary API process IPs, and laboratory partnerships, with offices in Shanghai, Hong Kong, Singapore, and the US. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Transo Pharm USA Company Banner

04

Seqens

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content

Propofol

About the Company : Founded in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. The company supports customers in the development, scale-up, and man...

Founded in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. The company supports customers in the development, scale-up, and manufacturing of drug substances from pre-clinical to commercial stages. Seqens offers a broad portfolio of APIs and proprietary products, along with custom solutions for healthcare, electronics, and cosmetics. With 15 industrial plants and 5 R&D centers worldwide, Seqens produces complex molecules across small- and large-scale requirements. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Seqens Company Banner

05

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Propofol

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNeuland Laboratories- A dedicated 100% API provider.

Flag India
Digital Content Digital Content

Propofol

About the Company : Neuland Laboratories, established in 1984 and headquartered in Hyderabad, is a publicly listed company offering solutions for pharmaceutical chemistry needs—from library compound...

Neuland Laboratories, established in 1984 and headquartered in Hyderabad, is a publicly listed company offering solutions for pharmaceutical chemistry needs—from library compounds to NCEs and advanced intermediates. It manufactures APIs and intermediates in USFDA-approved facilities, applying advanced process chemistry in a regulatory-compliant environment for clinical and commercial stages. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Neuland

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Flag India
Digital Content Digital Content

Propofol

About the Company : Supriya Lifescience Limited, established in 1987 and headquartered in Mumbai, is a globally recognized, technology-driven manufacturer of APIs, CDMO, and formulations. Its faciliti...

Supriya Lifescience Limited, established in 1987 and headquartered in Mumbai, is a globally recognized, technology-driven manufacturer of APIs, CDMO, and formulations. Its facilities in Lote and Ambernath are approved by USFDA, EUGMP, Health Canada, and other agencies. Specializing in antihistamines, antiallergics, vitamins, anesthetics, and anti-asthmatics, Supriya serves 1500+ customers in over 86 countries, with 15+ USDMFs, 10+ CEPs, and a 1050 KL manufacturing capacity. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Supriya

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content

Propofol

About the Company : Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), phytochemicals, herba...

Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), phytochemicals, herbal extracts, semi-finished granules, and finished formulations such as tablets, capsules, and dry suspensions. The company also provides product support through associate manufacturing plants for APIs, pellets, excipients, enzymes, and specialized chemicals, operating in compliance with cGMP, WHO-GMP, and EU-GMP standards. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Zeon Pharma Industries India Pvt Ltd

09

SNJ Labs

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSNJ Labs: WHO-GMP certified API leader in India, specializing in bulk drugs & intermediates with unmatched expertise.

Flag India
Digital Content Digital Content

Propofol

About the Company : SNJ Labs, established in 2013, is India’s largest manufacturer of Iron Sucrose, achieving a production capacity of 120 MT per year within five years. The company specializes in A...

SNJ Labs, established in 2013, is India’s largest manufacturer of Iron Sucrose, achieving a production capacity of 120 MT per year within five years. The company specializes in APIs and intermediates, including Alpha Ketoanalogues Calcium/Magnesium Salts and Ferric Carboxymaltose. Driven by strong product quality, an experienced doctorate-led management team, and global and domestic partnerships, SNJ Labs operates from advanced facilities in Rajkot, delivering consistent and reliable pharmaceutical solutions worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTogether we can improve the quality of life

Flag India
Digital Content Digital Content

Propofol

About the Company : Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with 26+ years in human and veterinary pharmaceuticals. Operating in 40+ countries, it owns two Gujarat facilities...

Shamrock Pharmachemi Pvt Ltd. is a globally recognized API leader with 26+ years in human and veterinary pharmaceuticals. Operating in 40+ countries, it owns two Gujarat facilities and partners with 16+ plants. Holding USFDA, EU-GMP, WHO-GMP, and other certifications, it is the largest exporter for 12 molecules worldwide. With robust regulatory compliance (DMF, CEP, ICH Q7), Shamrock is the preferred API partner in India. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Solubilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 2078-54-8 / Propofol API manufacturers, exporters & distributors?

Propofol manufacturers, exporters & distributors 1

37

PharmaCompass offers a list of Propofol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Propofol manufacturer or Propofol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Propofol manufacturer or Propofol supplier.

API | Excipient name

Propofol

Synonyms

2,6-diisopropylphenol, 2078-54-8, Diprivan, Disoprofol, Disoprivan, Fresofol

Cas Number

2078-54-8

Unique Ingredient Identifier (UNII)

YI7VU623SF

About Propofol

An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.

Propovan Manufacturers

A Propovan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Propovan, including repackagers and relabelers. The FDA regulates Propovan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Propovan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Propovan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Propovan Suppliers

A Propovan supplier is an individual or a company that provides Propovan active pharmaceutical ingredient (API) or Propovan finished formulations upon request. The Propovan suppliers may include Propovan API manufacturers, exporters, distributors and traders.

click here to find a list of Propovan suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Propovan USDMF

A Propovan DMF (Drug Master File) is a document detailing the whole manufacturing process of Propovan active pharmaceutical ingredient (API) in detail. Different forms of Propovan DMFs exist exist since differing nations have different regulations, such as Propovan USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Propovan DMF submitted to regulatory agencies in the US is known as a USDMF. Propovan USDMF includes data on Propovan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Propovan USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Propovan suppliers with USDMF on PharmaCompass.

Propovan JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Propovan Drug Master File in Japan (Propovan JDMF) empowers Propovan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Propovan JDMF during the approval evaluation for pharmaceutical products. At the time of Propovan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Propovan suppliers with JDMF on PharmaCompass.

Propovan KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Propovan Drug Master File in Korea (Propovan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Propovan. The MFDS reviews the Propovan KDMF as part of the drug registration process and uses the information provided in the Propovan KDMF to evaluate the safety and efficacy of the drug.

After submitting a Propovan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Propovan API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Propovan suppliers with KDMF on PharmaCompass.

Propovan CEP

A Propovan CEP of the European Pharmacopoeia monograph is often referred to as a Propovan Certificate of Suitability (COS). The purpose of a Propovan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Propovan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Propovan to their clients by showing that a Propovan CEP has been issued for it. The manufacturer submits a Propovan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Propovan CEP holder for the record. Additionally, the data presented in the Propovan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Propovan DMF.

A Propovan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Propovan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Propovan suppliers with CEP (COS) on PharmaCompass.

Propovan WC

A Propovan written confirmation (Propovan WC) is an official document issued by a regulatory agency to a Propovan manufacturer, verifying that the manufacturing facility of a Propovan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Propovan APIs or Propovan finished pharmaceutical products to another nation, regulatory agencies frequently require a Propovan WC (written confirmation) as part of the regulatory process.

click here to find a list of Propovan suppliers with Written Confirmation (WC) on PharmaCompass.

Propovan NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Propovan as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Propovan API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Propovan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Propovan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Propovan NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Propovan suppliers with NDC on PharmaCompass.

Propovan GMP

Propovan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Propovan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Propovan GMP manufacturer or Propovan GMP API supplier for your needs.

Propovan CoA

A Propovan CoA (Certificate of Analysis) is a formal document that attests to Propovan's compliance with Propovan specifications and serves as a tool for batch-level quality control.

Propovan CoA mostly includes findings from lab analyses of a specific batch. For each Propovan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Propovan may be tested according to a variety of international standards, such as European Pharmacopoeia (Propovan EP), Propovan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Propovan USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty